Name: KTSAVLQ-Rh110-gammaGlu
SKU: LS-4190
Availability: InStock

Grouped product items

Cantidad

Unidad de venta

Precio

Unidad de almacenamiento de stock (SKU)

Disponibilidad

2 mg

1.120,00 €

LS-4190.0002

5 mg

2.130,00 €

LS-4190.0005

10 mg

3.280,00 €

LS-4190.0010

description

SARS-CoV-2 main protease Mpro (3CLpro) represents a major target in drug development against COVID-19. Prior to cleavage, rhodamine is bound to glutamine and thus not fluorescent. Upon cleavage, the fluorophore becomes active. This rhodamine 110 based Mpro substrate has a red-shifted excitation (492 nm) and emission (529) compared to the FRET substrate LS-4180. It shows a better signal-to-noise ratio and produces less interference with potential inhibitors in screening assays. This leads to a higher sensitivity compared to the Dabcyl/Edans substrate. In consequence, lower substrate amounts are required for successful assays. Dissolve in dry DMSO and use as aliquots.

references

á-Ketoamides as Broad-Spectrum Inhibitors of Coronavirus and Enterovirus Replication: Structure-Based Design, Synthesis, and Activity Assessment; L. Zhang, D. Lin, Y. Kusov, Y. Nian, Q. Ma, J. Wang, A. von Brunn, P. Leyssen, K. Lanko, J. Neyts, A. de Wilde, E. J. Snijder, H. Liu, and R. Hilgenfeld; J. Med. Chem. 2020; 63: 4562-4578; https://doi.org/10.1021/acs.jmedchem.9b01828

A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters; K. H. G. Verschueren, K. Pumpor, S. Anemüller, S. Chen, J. R. Mesters, R. Hilgenfeld; Chem. Biol. 2008; 15: 597-606; https://doi.org/10.1016/j.chembiol.2008.04.011.

* Disclaimer

We refer to our general terms and conditions.
All information contained in our webshop is compiled to the best of our knowledge.
Prices and product availability are subject to change and require reconfirmation. Please contact us for further information.